CURE Global X S&P Biotech ETF
- 48.620
- -2.500-4.89%
ETFS S&P Biotech ETF: GGY: Compulsory Acquisition Notice Centaurus T/O - Form 6021
ETFS S&P Biotech ETF: Director Appointment and Resignation
ETFS S&P Biotech ETF: GGY Takeover Update
ETFS S&P Biotech ETF: Glengarry Achieves 90% Acceptance for Centaurus Share Offer
ETFS S&P Biotech ETF: GGYGlengarry Extends Offer Period for Centaurus Takeover Bid
ETFS S&P Biotech ETF: Results of AGM
ETFS S&P Biotech ETF: Appointment of Chairman/Withdrawal of AGM Resolutions 5 to 7
ETFS S&P Biotech ETF: Letter to Shareholders
ETFS S&P Biotech ETF: Glengarry and Centaurus to Merge
ETFS S&P Biotech ETF: Glengarry and Centaurus to Merge
ETFS S&P Biotech ETF: Director Resignation
ETFS S&P Biotech ETF: Notice of Annual General Meeting/Proxy Form
ETFS S&P Biotech ETF: Director Appointment - Mr Peter Freund
ETFS S&P Biotech ETF: Executive Appointments and Director Resignations
ETFS S&P Biotech ETF: Results of Meeting
ETFS S&P Biotech ETF: Results of Meeting